Bio-Techne (BSP:T1CH34) Change In Payables And Accrued Expense : R$140 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Change In Payables And Accrued Expense?

Bio-Techne's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was R$-140 Mil. It means Bio-Techne's Accounts Payable & Accrued Expense declined by R$140 Mil from Jun. 2024 to Sep. 2024 .

Bio-Techne's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2024 was R$150 Mil. It means Bio-Techne's Accounts Payable & Accrued Expense increased by R$150 Mil from Jun. 2023 to Jun. 2024 .

Bio-Techne Change In Payables And Accrued Expense Historical Data

The historical data trend for Bio-Techne's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Change In Payables And Accrued Expense Chart

Bio-Techne Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

29.39

266.78

116.95

-169.68

149.67

Bio-Techne Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-137.24	93.00	115.19	72.52	-140.31

Bio-Techne Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$140 Mil.

Bio-Techne Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

TECH:USA

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines